SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-13-019247
Filing Date
2013-04-01
Accepted
2013-04-01 16:55:32
Documents
10
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v332955_10k.htm 10-K 1306544
2 EXHIBIT 31.1 v332955_ex31-1.htm EX-31.1 12743
3 EXHIBIT 32.1 v332955_ex32-1.htm EX-32.1 5037
4 GRAPHIC tpg28.jpg GRAPHIC 7335
  Complete submission text file 0001144204-13-019247.txt   7056535

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT trgm-20121231.xml EX-101.INS 957379
6 XBRL TAXONOMY EXTENSION SCHEMA trgm-20121231.xsd EX-101.SCH 73352
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE trgm-20121231_cal.xml EX-101.CAL 48287
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE trgm-20121231_def.xml EX-101.DEF 321921
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE trgm-20121231_lab.xml EX-101.LAB 576456
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE trgm-20121231_pre.xml EX-101.PRE 393814
Mailing Address 2980 BEVERLY GLEN CIRCLE SUITE 301 LOS ANGELES CA 90077
Business Address 2980 BEVERLY GLEN CIRCLE SUITE 301 LOS ANGELES CA 90077 310-474-9809
Targeted Medical Pharma, Inc. (Filer) CIK: 0001420030 (see all company filings)

IRS No.: 205863618 | Fiscal Year End: 1209
Type: 10-K | Act: 34 | File No.: 000-53071 | Film No.: 13731918
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1